Key facts
- Bonebridge’s last known valuation is $7.0M (Jan 2025).
- It has raised $1.1M; the latest was Angel (individual) ($1.1M) in Jan 2025.
- Notable investors include Marcaro.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Bonebridge
- ·The full record, as it builds
Funding rounds
No funding rounds for Bonebridge are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Bonebridge
Manufacturer of orthopaedic trauma implants designed to simplify fracture care and improve surgical efficiency. The company designs, develops, and produces a streamlined portfolio of fracture fixation implants and instrument sets that cover most trauma indications using just two core systems, enabling surgeons and hospitals to standardize operating room workflows, shorten training requirements, and deliver reliable outcomes for patients.
- Sector
- Healthcare
- HQ
- Zug, Switzerland
- Founded
- 2018
- Employees
- 44
- Website
- bonebridge.ch/
- Ownership
- Privately Held (backing)
Bonebridge doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Bonebridge shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Bonebridge in its N-PORT filings yet. We sweep new filings monthly.